Form Type: 4

SEC EDGAR Link
Accession Number:0000950103-21-003634
Date:2021-03-03
Issuer: ROYALTY PHARMA PLC (RPRX)
Original Submission Date:

Reporting Person:

COYNE TERRANCE P.
C/O ROYALTY PHARMA PLC
110 EAST 59TH STREET NEW YORK, NY 10022

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
CLASS A ORDINARY SHARES 2021-03-03 S 29,820 d $43.71 270,180 indirect
CLASS A ORDINARY SHARES 2021-03-03 S 57,723 d $45.09 212,457 indirect
CLASS A ORDINARY SHARES 2021-03-03 S 11,001 d $45.86 201,456 indirect
CLASS A ORDINARY SHARES 2021-03-03 S 1,456 d $46.83 200,000 indirect
CLASS A ORDINARY SHARES 0 $0.00 1,500 direct
CLASS A ORDINARY SHARES 0 $0.00 1,450 indirect
CLASS A ORDINARY SHARES 0 $0.00 23,270 indirect
CLASS A ORDINARY SHARES 0 $0.00 24,170 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the reported price in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $43.47 to $44.46 per share. the holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f2 the reported price in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $44.50 to $45.46 per share. the holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f3 the reported price in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $45.57 to $46.41 per share. the holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Elevate your investments